The proof is in the pudding: patient engagement in studying cannabidiol in mild cognitive impairment

The proof is in the pudding: patient engagement in studying cannabidiol in mild cognitive impairment

Abstract Background Patient engagement (PE) in clinical trials has gained importance yet remains uncommon, particularly in patients with mild cognitive impairment (MCI), a critical precursor to Alzheimer’s disease (AD). Cannabidiol (CBD) shows potential in slowing MCI progression due to its neuropro...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy: Antonia Keck, Julia-Sophia Scheuermann, Petra Scheerbaum, Elmar Graessel, Kirsten R. Müller-Vahl
Format: Artykuł
Język:English
Wydane: BMC 2025-01-01
Seria:BMC Complementary Medicine and Therapies
Hasła przedmiotowe:
Mild cognitive impairment
Alzheimer’s disease
Cannabidiol
Cannabis-based medicine
Patient engagement
Patient and public involvement
Dostęp online:https://doi.org/10.1186/s12906-025-04753-w

Internet

https://doi.org/10.1186/s12906-025-04753-w

Podobne zapisy